Literature DB >> 27752882

Gene expression, signal transduction pathways and functional networks associated with growth of sporadic vestibular schwannomas.

Hjalte C R Sass1, Rehannah Borup2, Mikkel Alanin3, Finn Cilius Nielsen2,4, Per Cayé-Thomasen3,4.   

Abstract

The objective of this study was to determine global gene expression in relation to Vestibular schwannomas (VS) growth rate and to identify signal transduction pathways and functional molecular networks associated with growth. Repeated magnetic resonance imaging (MRI) prior to surgery determined tumor growth rate. Following tissue sampling during surgery, mRNA was extracted from 16 sporadic VS. Double stranded cDNA was synthesized from the mRNA and used as template for in vitro transcription reaction to synthesize biotin-labeled antisense cRNA, which was hybridized to Affymetrix HG-U133A arrays and analyzed by dChip software. Differential gene expression was defined as a 1.5-fold difference between fast and slow growing tumors (><0.5 ccm/year), employing a p-value <0.01. Deregulated transcripts were matched against established gene ontology. Ingenuity Pathway Analysis was used for identification of signal transduction pathways and functional molecular networks associated with tumor growth. In total 109 genes were deregulated in relation to tumor growth rate. Genes associated with apoptosis, growth and cell proliferation were deregulated. Gene ontology included regulation of the cell cycle, cell differentiation and proliferation, among other functions. Fourteen pathways were associated with tumor growth. Five functional molecular networks were generated. This first study on global gene expression in relation to vestibular schwannoma growth rate identified several genes, signal transduction pathways and functional networks associated with tumor progression. Specific genes involved in apoptosis, cell growth and proliferation were deregulated in fast growing tumors. Fourteen pathways were associated with tumor growth. Generated functional networks underlined the importance of the PI3K family, among others.

Entities:  

Keywords:  Acoustic neuroma; Gene ontology; Ingenuity pathway analysis; Molecular biology

Mesh:

Substances:

Year:  2016        PMID: 27752882     DOI: 10.1007/s11060-016-2292-9

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  39 in total

1.  Constitutive neuregulin-1/ErbB signaling contributes to human vestibular schwannoma proliferation.

Authors:  Marlan R Hansen; Pamela C Roehm; Papri Chatterjee; Steven H Green
Journal:  Glia       Date:  2006-04-15       Impact factor: 7.452

Review 2.  The non-muscle functions of actinins: an update.

Authors:  Kate S Foley; Paul W Young
Journal:  Biochem J       Date:  2014-04-01       Impact factor: 3.857

3.  A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor.

Authors:  J A Trofatter; M M MacCollin; J L Rutter; J R Murrell; M P Duyao; D M Parry; R Eldridge; N Kley; A G Menon; K Pulaski
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

4.  Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus.

Authors:  Wei Li; Liru You; Jonathan Cooper; Gaia Schiavon; Angela Pepe-Caprio; Lu Zhou; Ryohei Ishii; Marco Giovannini; C Oliver Hanemann; Stephen B Long; Hediye Erdjument-Bromage; Pengbo Zhou; Paul Tempst; Filippo G Giancotti
Journal:  Cell       Date:  2010-02-19       Impact factor: 41.582

5.  Proteomic screening identifies a YAP-driven signaling network linked to tumor cell proliferation in human schwannomas.

Authors:  Alizée Boin; Anne Couvelard; Christophe Couderc; Isabel Brito; Dan Filipescu; Michel Kalamarides; Pierre Bedossa; Leanne De Koning; Carine Danelsky; Thierry Dubois; Philippe Hupé; Daniel Louvard; Dominique Lallemand
Journal:  Neuro Oncol       Date:  2014-02-20       Impact factor: 12.300

6.  Immunohistochemical demonstration of vascular endothelial growth factor in vestibular schwannomas correlates to tumor growth rate.

Authors:  Per Cayé-Thomasen; Lone Baandrup; Grete Krag Jacobsen; Jens Thomsen; Sven-Eric Stangerup
Journal:  Laryngoscope       Date:  2003-12       Impact factor: 3.325

7.  Phosphatidylinositol 3-kinase/AKT pathway activation in human vestibular schwannoma.

Authors:  Abraham Jacob; Tina X Lee; Brian A Neff; Shyra Miller; Bradley Welling; Long-Sheng Chang
Journal:  Otol Neurotol       Date:  2008-01       Impact factor: 2.311

8.  Gene-expression profiling elucidates molecular signaling networks that can be therapeutically targeted in vestibular schwannoma.

Authors:  Sameer Agnihotri; Isabel Gugel; Marc Remke; Antje Bornemann; Georgios Pantazis; Stephen C Mack; David Shih; Sanjay K Singh; Nesrin Sabha; Michael D Taylor; Marcos Tatagiba; Gelareh Zadeh; Boris Krischek
Journal:  J Neurosurg       Date:  2014-09-23       Impact factor: 5.115

9.  Merlin, the product of the Nf2 tumor suppressor gene, is an inhibitor of the p21-activated kinase, Pak1.

Authors:  Joseph L Kissil; Erik W Wilker; Kristen C Johnson; Matthew S Eckman; Michael B Yaffe; Tyler Jacks
Journal:  Mol Cell       Date:  2003-10       Impact factor: 17.970

10.  The NF2 tumor suppressor regulates microtubule-based vesicle trafficking via a novel Rac, MLK and p38(SAPK) pathway.

Authors:  R F Hennigan; C A Moon; L M Parysek; K R Monk; G Morfini; S Berth; S Brady; N Ratner
Journal:  Oncogene       Date:  2012-04-23       Impact factor: 9.867

View more
  4 in total

1.  Convolutional Neural Networks to Detect Vestibular Schwannomas on Single MRI Slices: A Feasibility Study.

Authors:  Carole Koechli; Erwin Vu; Philipp Sager; Lukas Näf; Tim Fischer; Paul M Putora; Felix Ehret; Christoph Fürweger; Christina Schröder; Robert Förster; Daniel R Zwahlen; Alexander Muacevic; Paul Windisch
Journal:  Cancers (Basel)       Date:  2022-04-20       Impact factor: 6.575

Review 2.  The role of mRNA in the development, diagnosis, treatment and prognosis of neural tumors.

Authors:  Yiyang Zheng; Yanyan Luo; Xixi Chen; Huiting Li; Baojun Huang; Baofeng Zhou; Liqing Zhu; Xianhui Kang; Wujun Geng
Journal:  Mol Cancer       Date:  2021-03-05       Impact factor: 27.401

3.  Epidemiology Of Vestibular Schwannomas - Prospective 40-Year Data From An Unselected National Cohort.

Authors:  Martin Reznitsky; Mette Marie Babiel Schmidt Petersen; Niels West; Sven-Eric Stangerup; Per Cayé-Thomasen
Journal:  Clin Epidemiol       Date:  2019-11-08       Impact factor: 4.790

4.  Inflammation and vascular permeability correlate with growth in sporadic vestibular schwannoma.

Authors:  Daniel Lewis; Federico Roncaroli; Erjon Agushi; Dominic Mosses; Ricky Williams; Ka-Loh Li; Xiaoping Zhu; Rainer Hinz; Ross Atkinson; Andrea Wadeson; Sharon Hulme; Helen Mayers; Emma Stapleton; Simon K L Lloyd; Simon R Freeman; Scott A Rutherford; Charlotte Hammerbeck-Ward; D Gareth Evans; Omar Pathmanaban; Alan Jackson; Andrew T King; David J Coope
Journal:  Neuro Oncol       Date:  2019-02-19       Impact factor: 12.300

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.